Nanobiotix Discloses Insider Transactions
Ticker: NBTX · Form: 6-K · Filed: Dec 16, 2024 · CIK: 1760854
Sentiment: neutral
Topics: insider-transaction, disclosure, 6-K
TL;DR
Nanobiotix filed a 6-K on Dec 16, 2024, reporting insider transactions.
AI Summary
On December 16, 2024, Nanobiotix S.A. disclosed transactions by individuals in managerial positions. The filing, a Form 6-K, serves as a report of a foreign private issuer for the month of December 2024, detailing these disclosures.
Why It Matters
This filing provides transparency into the trading activities of Nanobiotix's management, which can offer insights into their confidence in the company's future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of managerial transactions and does not inherently present new risks.
Key Players & Entities
- Nanobiotix S.A. (company) — Registrant
- December 16, 2024 (date) — Filing date and reporting period
FAQ
What type of filing is Nanobiotix S.A. submitting?
Nanobiotix S.A. is submitting a Form 6-K, which is a Report of Foreign Private Issuer.
What is the primary purpose of this Form 6-K filing?
The primary purpose is to provide notification and public disclosure of transactions by persons discharging managerial responsibilities.
When was this report filed with the SEC?
This report was filed on December 16, 2024.
What is the principal executive office address for Nanobiotix S.A.?
The principal executive office is located at 60 rue de Wattignies, 75012 Paris, France.
What is the SEC file number for Nanobiotix S.A.?
The SEC file number for Nanobiotix S.A. is 001-39777.
Filing Stats: 192 words · 1 min read · ~1 pages · Grade level 12.2 · Accepted 2024-12-16 11:32:49
Filing Documents
- a6-kformmanagerstransactio.htm (6-K) — 11KB
- exhibit991december16.htm (EX-99.1) — 33KB
- exhibit991december16001.jpg (GRAPHIC) — 84KB
- exhibit991december16002.jpg (GRAPHIC) — 43KB
- exhibit991december16003.jpg (GRAPHIC) — 121KB
- exhibit991december16004.jpg (GRAPHIC) — 55KB
- exhibit991december16005.jpg (GRAPHIC) — 86KB
- exhibit991december16006.jpg (GRAPHIC) — 43KB
- exhibit991december16007.jpg (GRAPHIC) — 121KB
- exhibit991december16008.jpg (GRAPHIC) — 55KB
- 0001760854-24-000014.txt ( ) — 882KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NANOBIOTIX S.A. Date December 16, 2024 By Bart Van Rhijn , Chief Financial Officer 3